Pathstone Holdings’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.6M Sell
56,403
-2,478
-4% -$1.08M 0.07% 193
2026
Q1
$27.1M Buy
58,881
+5,014
+9% +$2.54M 0.11% 139
2025
Q4
$30.5M Buy
53,867
+5,440
+11% +$2.9M 0.12% 132
2025
Q3
$21.7M Sell
48,427
-2,711
-5% -$1.3M 0.08% 164
2025
Q2
$27.8M Buy
51,138
+2,070
+4% +$1.08M 0.11% 119
2025
Q1
$24.3M Buy
49,068
+849
+2% +$470K 0.11% 141
2024
Q4
$25.2M Sell
48,219
-709
-1% -$369K 0.11% 122
2024
Q3
$24M Buy
48,928
+1,228
+3% +$572K 0.11% 138
2024
Q2
$21.2M Buy
47,700
+291
+0.6% +$116K 0.1% 146
2024
Q1
$18.9M Buy
47,409
+3,991
+9% +$1.51M 0.09% 164
2023
Q4
$14.7M Buy
+43,418
New +$12.9M 0.08% 188

Other funds holding ISRG

Pathstone Holdings's ISRG Position: Q2 2026 in Review

Pathstone Holdings reduced its Intuitive Surgical (ISRG) stake by 4.2% in Q2 2026, selling an estimated $1.08M and leaving 56,403 shares worth $22.6M. The position accounts for 0.07% of the portfolio, ranked #193.

Pathstone Holdings first reported a position in ISRG in Q4 2023 and has held it in 11 quarters since. The position peaked at $30.5M in Q4 2025. 2,232 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Pathstone Holdings held 56,403 shares of Intuitive Surgical worth $22.6M as of Q2 2026.
  • Pathstone Holdings sold 2,478 Intuitive Surgical shares in Q2 2026, an estimated $1.08M.
  • Intuitive Surgical made up 0.07% of Pathstone Holdings's portfolio in Q2 2026, its #193 holding.
  • Pathstone Holdings first reported a position in Intuitive Surgical in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Intuitive Surgical position peaked at $30.5M in Q4 2025.
  • 2,232 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.